PDGFRβ,VSMC

Xueqing Tang1, Dannya Estau2, Xiaoru Huang2

  • 1Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital; Beijing Key Laboratory of Cardiovascular Receptors Research; Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health; State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing 100191, China.

Life sciences
|March 20, 2025
PubMed
概括

埃达拉 (EDA) 向PDGFRβ,有效地抑制与心血管疾病相关的血管光滑肌细胞 (VSMC) 过渡. 这种重新设计的药物为与VSMC相关的疾病提供了新的治疗途径.